Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
11 participants
INTERVENTIONAL
2014-09-30
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hence, there is no hypothesis as such.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Generation of Biological Samples Positive to Salmeterol for Anti-Doping Control
NCT04195867
Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?
NCT04402658
Salmeterol Effect on Exercise Performance
NCT06655012
Terbutaline Concentrations in Blood and Urine
NCT00914797
Physiological Response to Salbutamol and Exercise
NCT03902106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
salmeterol
Salmeterol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Salmeterol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-45 years
* Healthy
Exclusion Criteria
* Smoking
* Habitual use of medicine
* Allergy towards salmeterol
* Unable to exercise on a bike ergometer
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Nielsen
MSc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vibeke Backer, Professor
Role: PRINCIPAL_INVESTIGATOR
Bispebjerg Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital
Copenhagen, Select State, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WADA2013sal
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.